Updated Jul 16, 2026
SCHULMAN AMY W has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $7K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 838 | $0.00 | |
| 2026-05-15 | ELV | Elevance Health, Inc. | A — Grant or award | 563 | $0.00 | |
| 2026-05-14 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | M — Option exercise | 11.2K | $70.20 | $790K |
| 2026-03-23 | ELV | Elevance Health, Inc. | S — Open-market sale | 26 | $287.50 | $7K |
| 2026-02-03 | ELV | Elevance Health, Inc. | A — Grant or award | 218 | $0.00 | |
| 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 775 | $0.00 |
SCHULMAN AMY W is a corporate insider — currently tracked as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($7K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SCHULMAN AMY W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.